PDF) Inferring cancer dependencies on metabolic genes from large-scale genetic screens
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Network expansion of genetic associations defines a pleiotropy map of human cell biology | bioRxiv
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Edmond J. Safra Bioinformatics Center
Shlomi Tomer - T3
Anna Pimenova, PhD - R&D Project Manager - Immunai | LinkedIn
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
The FASEB Journal: Vol 33, No 1
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Edmond J. Safra Bioinformatics Center
Systems Biology Delivers Higher Level Analysis
Tomer Shlomi | AIChE
5th Conference on Constraint-Based Reconstruction and Analysis (COBRA 2018) | AIChE
7th Conference on Constraint-Based Reconstruction and Analysis (COBRA 2021) | AIChE
Tel Aviv University's 2018 TAU Review by telavivuni - Issuu
Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network | PNAS
Shlomi Tomer - T3
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Network expansion of genetic associations defines a pleiotropy map of human cell biology | bioRxiv
Tomer Shlomi's research works | Technion - Israel Institute of Technology, Haifa (technion) and other places
Model-based identification of drug targets that revert disrupted metabolism and its application to ageing | Nature Communications
